Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Heron Therapeutics Inc (NASDAQ: HRTX) was $1.68 for the day, down -5.08% from the previous closing price of $1.77. In other words, the price has decreased by -$5.08 from its previous closing price. On the day, 1.43 million shares were traded.
Ratios:
Our analysis of HRTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.74 and its Current Ratio is at 2.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.
Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.86.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is 1.14%, while the 200-Day Moving Average is calculated to be -23.37%.
Shares Statistics:
A total of 151.70M shares are outstanding, with a floating share count of 150.77M. Insiders hold about 0.87% of the company’s shares, while institutions hold 75.77% stake in the company.
